Logo-bi
Original Research

1. Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression
Ysrafil Ysrafil* ORCID, Indwiani Astuti ORCID
BioImpacts. 2022;12(3): 195-202. doi: 10.34172/bi.2021.22119
PMCID: PMC9124874     PMID: 35677668     Scopus ID: 85132077892    
Article
PDF
Full Text
XML
Cited By:
4
1
0
Chitosan nanoparticle antimiRNA-324-5p could inhibit ovarian cancer proliferation by reduce endogenous miRNA-324-5p to lead restoration of MEN1 and generates repression of GLI1 expression.
Editorial

2. Exosomes as versatile nanoscaled biocompartments in cancer therapy and/or resistance
Yalda Rahbar Saadat ORCID, Jaleh Barar* ORCID
BioImpacts. 2022;12(2): 87-88. doi: 10.34172/bi.2022.24253
PMCID: PMC8905586     PMID: 35411296     Scopus ID: 85127210127    
Article
PDF
Full Text
XML
Cited By:
2
1
1
Jaleh Barar (PharmD, Ph.D.) is a Full Professor at the Faculty of Pharmacy, Tabriz University of Medical Sciences. Professor Barar is working on various aspects of pharmaceutical cell biology with particular emphasis on the development of novel drug delivery/targeting systems. Dr Barar is listed among top 1% of world scientists based on ESI ranking system.
Original Article

3. Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL)

Fateme Arjmand ORCID, Samaneh Shojaei, Mitra Khalili, Hossein Dinmohammadi, Behzad Poopak, Samira Mohammadi-Yeganeh* ORCID, Yousef Mortazavi* ORCID
Bioimpacts. 2024;14(4): 28870. doi: 10.34172/bi.2023.28870
PMCID: PMC11298021     PMID: 39104620    
Article
PDF
Full Text
XML
Cited By:
0
0
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge